Modulating temporal control of NF-kappaB activation: implications for therapeutic and assay selection.

The activation of transcription factor NF-kappaB (nuclear factor-kappaB) plays a central role in the induction of many inflammatory response genes. This process is characterized by either oscillations or stable induction of NF-kappaB nuclear binding. Changes in dynamics of binding result in the expression of distinct subsets of genes leading to different physiological outcomes. We examined NF-kappaB DNA binding activity in lipopolysaccharide (LPS)-stimulated IC-21 cells by electromobility shift assay and nonradioactive transcription factor assay and interpreted the results using a kinetic model of NF-kappaB activation. Both assays detected damped oscillatory behavior of NF-kappaB with differences in sensitivity and reproducibility. 3,4-Dichloropropionaniline (DCPA) was used to modulate the oscillatory behavior of NF-kappaB after LPS stimulation. DCPA is known to inhibit the production of two NF-kappaB-inducible cytokines, IL-6 and tumor necrosis factor alpha, by reducing but not completely abrogating NF-kappaB-induced transcription. DCPA treatment resulted in a potentiation of early LPS-induced NF-kappaB activation. The nonradioactive transcription factor assay, which has a higher signal/noise ratio than the electromobility shift assay, combined with in silico modeling, produced results that revealed changes in NF-kappaB dynamics which, to the best of our knowledge, have never been previously reported. These results highlight the importance of cell type and stimulus specificity in transcription factor activity assessment. In addition, assay selection has important implications for network inference and drug discovery.

[1]  J A Jacquez,et al.  Parameter estimation: local identifiability of parameters. , 1990, The American journal of physiology.

[2]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[3]  Marek Kimmel,et al.  Stochastic regulation in early immune response. , 2006, Biophysical journal.

[4]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[5]  D B Kell,et al.  Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.

[6]  T. Gilmore,et al.  Inhibitors of NF-kappaB signaling: 785 and counting. , 2006, Oncogene.

[7]  John Maddox,et al.  Is molecular biology yet a science? , 1992, Nature.

[8]  Claudio Cobelli,et al.  Global identifiability of nonlinear models of biological systems , 2001, IEEE Transactions on Biomedical Engineering.

[9]  Patricia Renard,et al.  Development of a sensitive multi-well colorimetric assay for active NFκB , 2001 .

[10]  M. M. Garner,et al.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system , 1981, Nucleic Acids Res..

[11]  J. Barnett,et al.  The immunomodulatory effects of the herbicide propanil on murine macrophage interleukin-6 and tumor necrosis factor-alpha production. , 1997, Toxicology and applied pharmacology.

[12]  A. Revzin.  Gel electrophoresis assays for DNA-protein interactions. , 1989, BioTechniques.

[13]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[14]  Yingle Liu,et al.  The IRAK-1-BCL10-MALT1-TRAF6-TAK1 Cascade Mediates Signaling to NF-κB from Toll-like Receptor 4* , 2006, Journal of Biological Chemistry.

[15]  P. Marrack,et al.  Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Nathan,et al.  Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.

[17]  E. Unanue.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. , 1981, Advances in immunology.

[18]  T. Gilmore,et al.  Inhibitors of NF-κB signaling: 785 and counting , 2006, Oncogene.

[19]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[20]  J. Barnett,et al.  Propanil Inhibits Tumor Necrosis Factor-α Production by Reducing Nuclear Levels of the Transcription Factor Nuclear Factor-κB in the Macrophage Cell Line IC-21 , 2001 .

[21]  S. Bustin,et al.  An enzyme-linked immunosorbent assay for the detection of agents which interfere with the DNA binding activities of transcription factors--exemplified by NF-IL6. , 1998, Analytical biochemistry.

[22]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[23]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[24]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[25]  E. Kopp,et al.  NF-kappa B and rel proteins in innate immunity. , 1995, Advances in immunology.

[26]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[27]  John Maddox.  Towards more measurement in biology , 1994, Nature.

[28]  J. Barnett,et al.  Inhibitory effect of 3,4‐dichloropropionaniline on cytokine production by macrophages is associated with LPS‐mediated signal transduction , 1997, Journal of leukocyte biology.

[29]  D. Crothers,et al.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. , 1981, Nucleic acids research.

[30]  B. Britigan,et al.  Role of oxidants in microbial pathophysiology , 1997, Clinical microbiology reviews.

[31]  M F Hoylaerts,et al.  Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. , 1997, Analytical biochemistry.

[32]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[33]  W. Hendrickson.  Protein-DNA interactions studied by the gel electrophoresis-DNA binding assay , 1985 .

[34]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[35]  David Baltimore,et al.  Achieving stability of lipopolysaccharide-induced NF-kappaB activation. , 2005, Science.

[36]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[37]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[38]  A. Hoffmann,et al.  Circuitry of nuclear factor kappaB signaling. , 2006, Immunological reviews.

[39]  S. Ghosh,et al.  Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .

[40]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[41]  James T. Wassell,et al.  Bootstrap Methods: A Practitioner's Guide , 2001, Technometrics.

[42]  J. Remacle,et al.  Development of a sensitive multi-well colorimetric assay for active NFkappaB. , 2001, Nucleic acids research.

[43]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[44]  J. Barnett,et al.  3,4-dichloropropionaniline suppresses normal macrophage function. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  Alexander Hoffmann,et al.  IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.

[46]  D. Baltimore,et al.  Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation , 2005, Science.

[47]  E. Unanue.  Antigen-presenting function of the macrophage. , 1984, Annual review of immunology.